LENTIPAC
USPTO Trademark Record · Serial No. 78714132
Trademark details
It was initially claimed by Lentigen Corporation on 20050915.
That brand applies to the following goods and services:Biochemicals, namely, monoclonal antibodies for in vitro scientific or research use; Diagnostic preparations for scientific or research use, Cells for medical or clinical use; Clinical medical reagents; Diagnostic reagents for clinical or medical laboratory use; Drug delivery agents consisting compounds that facilitate delivery of a wide range of pharmaceuticals, Contract manufacturing in the field of biopharmaceuticals, including without limitation lentiviral vectors, Development of new technology for others in the field of drug discovery and validation, gene expression and delivery, genomics research, protein and monoclonal antibody production; Medical and scientific research, namely conducting clinical trials; Pharmaceutical drug development services; Structural and functional anaylisis of genomes.
Currently that trademark is represented by trademark attorney(s): Eric S. Marzluf.
You can learn more about that trademark on the USPTO website: View the USPTO record
Services available
Questions about this trademark?
If you have questions or issues related to the LENTIPAC trademark — or to trademarks in general — our trademark attorneys can help. No appointment needed: call us or request a free estimate.
Register a Trademark Get a Free Estimate
